Navigation Links
The latest science and treatments in emergency cardiac care
Date:9/7/2012

More than 400 scientific abstracts will be presented by international scientists, providing a great source of news stories for journalists. The full scientific programme is available here.

"This first annual Congress of the new Association will highlight the importance of various professionals working together to improve the outcomes of patients with acute cardiovascular disease," said Professor Peter Clemmensen (Denmark), president of ACCA. "It will focus on all acute cardiovascular disease cases admitted acutely, from the pre-hospital phase to the emergency room, and the stays in the coronary care unit and intensive cardiac care unit."

Over 40 sessions will be held on myocardial infarction, acute coronary syndromes, acute heart failure, life threatening arrhythmias, sudden cardiac death, resuscitation, acute valvular diseases and general intensive care.

Experts from around the globe will provide comprehensive updates on diagnosis, systems of care and therapies, including state of the art technology and devices.

Professor Christiaan Vrints (Belgium), former chairman of the ESC Working Group on Acute Cardiac Care and past-president of ACCA, said:

"There will be innovative information on the management of acute heart failure, cardiogenic shock, acute arrhythmias and acute coronary syndromes."

Professor Bulent Gorenek (Turkey), chair of the scientific programme and local host of Acute Cardiac Care 2012, added:

"Myocardial infarction is the number one cause of death in developed countries. The novel developments in diagnosis and treatment discussed at the Congress will be of great interest not only to cardiologists, but also to journalists and the public who all need to know how to react when faced with a heart attack".

For the first time this year experts will present challenging clinical cases in acute cardiology from their daily practice. Management of cases and implementation of guidelines1 will be discussed with the audience and experts will provide recommendations for daily practice.

The Acute Cardiac Care Congress attracts cardiologists, emergency physicians, nurses, paramedics, surgeons and technicians. This multidisciplinary flavour is reflected in the main theme of the Congress, "Integrative approach and management of Acute Cardiovascular Diseases".

The Cardiologists of Tomorrow will have an increasing role at the Congress by organising scientific and educational sessions, including a challenging case in cardiogenic shock, and chairing some sessions.

Professor Clemmensen said:

"Becoming an Association of the ESC has increased our visibility within the ESC and beyond and we hope that this will boost attendance at the Congress in Istanbul."

Professor Gorenek concluded:

"Istanbul is the cultural and finance capital of Turkey. With a population of more than 11 million, it is a unique city that connects the two continents of Europe and Asia."


'/>"/>

Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
2. Elinext Leverages Latest QR Code and NFC Technologies in Mobile App Development for Retailers, Manufacturers, Advertisers, and Real Estate Companies
3. UT Southwestern investigators awarded $48.2 million in latest round of CPRIT grants
4. Meeting in Jordan to educate medical professionals on latest advances in osteoporosis
5. Washingtons Life Sciences Discovery Fund awards commercialization grants
6. Hutchinson Center president elected to American Academy of Art and Sciences
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. Ivy Neurological Sciences Internship program funded at TGen
9. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
10. Understanding and promoting mental health - Insights from psychological science
11. The Science Media Centre, London, wins the 2012 ECNP Media Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... PHILADELPHIA , Oct. 2, 2017 Halo Labs announces ... particle analysis system called the HORIZON at MIBio 2017 in ... analyzes subvisible and visible particulate matter in biopharmaceutical samples with unprecedented ... use of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: